Alivus Life Sciences Ltd

NSE: ALIVUS · BSE: 543322 · Pharmaceuticals & Biotechnology · 23 announcements

Share price: ₹1,384.70
Market cap: ₹17,000 Cr
Revenue (annual): ₹2,552 Cr
Net profit (annual): ₹564.5 Cr
P/E (TTM): 28.2×Sector 47.4×
Promoter holding: 74.87%+0.00% QoQ
FII holding: 5.54%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Financial Results 4 Results Update 2 Merger & Restructuring 2 Employee Stock Options 2 Board Meeting Date 2 Annual General Meeting 2 Other Announcement 1 Debt & Borrowing 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

11 Aug 2026 18:04 IST BSE

Business Update

Alivus Life Sciences Business Update

Alivus Life Sciences submitted its Business Responsibility & Sustainability Report for FY 2025-26, detailing operational metrics, employee statistics, and sustainability performance.

Read the filing ↗